Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer

NCT02364557 is registered in ClinicalTrials.gov with NRG Oncology as lead sponsor.

NCT NCT02364557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02364557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
Lead sponsor
NRG Oncology
Phase
Phase 2/3
Overall status
Completed
Start date
December 24, 2014
Completion date
September 4, 2025
Enrollment
129 (actual)
Sites
162

Conditions

As the registry lists them; a condition with its own page is linked.

anatomic stage iv breast cancer ajcc v8, anatomic stage iv breast cancer american joint committee on cancer (ajcc) v8, metastatic breast carcinoma, metastatic malignant neoplasm in the bone, metastatic malignant neoplasm in the liver, metastatic malignant neoplasm in the lung, metastatic malignant neoplasm in the lymph nodes, metastatic malignant neoplasm in the spine, prognostic stage iv breast cancer ajcc v8